J.P. Morgan Life Sciences Private Capital is partnering with Blue Horizon Advisors to host the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit in Abu Dhabi on May 14 – 15th, 2024. The annual event seeks to attract top caliber, early stage entrepreneurs in life sciences to compete for top prizes and seed the growth of the emerging scientific innovation hub in Abu Dhabi. The Summit will take place in conjunction with the 2024 Abu Dhabi Global Healthcare Week (ADGHW).
J.P. Morgan’s two-day Summit aims to bring together the life sciences leaders of today and the leaders of tomorrow who are building a wide range of innovative therapeutic solutions for diseases prevalent in the Emirati region. Examples of these include, but are not limited to, diabetes, obesity, cardiometabolic disease, oncology, sickle cell anemia, cystic fibrosis, lysosomal storage disease, and rare monogenic disorders.
Applications close on January 22, 2024.
Upon review of applications, J.P. Morgan Life Sciences Private Capital will invite 10 emerging companies to pitch to an industry-renowned judges panel. Two finalists will be awarded prize money and potential support from J.P. Morgan Life Sciences Private Capital.
Summit Agenda:
- Absorb invaluable insights from our inspiring two-days:
- Keynote speeches by industry-leading entrepreneurs and scientists
- Networking opportunities
- On-site visits to newly developed innovation centers in Abu Dhabi
- Private one-on-one meetings between finalists, J.P. Morgan Life Sciences Private Capital and the judges
- Pitch presentations by the next generation of innovators
Select companies will be further analyzed by J.P. Morgan’s Life Sciences Private Capital team.
More information and application at J.P. Morgan's event website.